Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis

NCT00238342 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00238342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00238342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis
Lead sponsor
Gynecologic Oncology Group
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2005
Completion date
Not reported
Enrollment
2,000 (estimated)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer